In vitro evidence of possible influence of scutellarein towards bile acids' metabolism

被引:13
|
作者
Shu-Yao, Z. [1 ]
Hong, J. [2 ]
Chao-Xian, L. [3 ]
Zhi-Wei, Z. [1 ]
Xin, Dai-Shan [1 ]
Lei, C. [4 ]
机构
[1] Shantou Univ, Coll Med, Canc Hosp, Dept Pharm, Shantou 515031, Guangdong, Peoples R China
[2] Shantou Univ, Coll Med, Canc Hosp, CT Lab, Shantou 515031, Guangdong, Peoples R China
[3] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Pharm, Shantou 515031, Guangdong, Peoples R China
[4] Shantou Univ, Coll Med, Canc Hosp, Shantou 515031, Guangdong, Peoples R China
关键词
scutellarein; bile acids metabolism; in vitro methods; IONIZATION MASS-SPECTROMETRY; HUMAN URINE; GLUCURONIDATION; SEPARATION; RECEPTOR; LIVER;
D O I
10.4314/ahs.v13i3.4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The glucuronidation process has been regarded as the key elimination process for toxic bile acids. UDP-glucuronosyltransferase (UGT) 1A3 is one important metabolizing enzyme involved in this process. Objective: To evaluate the inhibition of UGT1A3 by scutellarein which is an important herbal ingredient using in vitro method, trying to indicate the possibility of toxicity due to the accumulation of toxic bile acids. Methods: Due to the difficulty to gain the standards of biles acids' glucuronides, the recombinant UGT1A3-catalyzed 4-methylumbelliferone (4-MU) glucuronidation reaction was employed to profile the activity of UGT1A3. Results: The results showed that scutellarein inhibited UGT1A3 in a concentration-dependent behaviour. Competitive inhibition was demonstrated using both Dixon plot and Lineweaver-Burk plot, and the inhibition kinetic parameter (K-i) was calculated to be 5.8uM. Conclusion: All these data reminded the necessary monitoring of the levels of bile acids in plasma when utilizing scutellarein and the herbs containing this compound.
引用
收藏
页码:556 / 559
页数:4
相关论文
共 50 条
  • [31] A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders
    Fang, Zhong-Ze
    He, Rong-Rong
    Cao, Yun-Feng
    Tanaka, Naoki
    Jiang, Changtao
    Krausz, Kristopher W.
    Qi, Yunpeng
    Dong, Pei-Pei
    Ai, Chun-Zhi
    Sun, Xiao-Yu
    Hong, Mo
    Ge, Guang-Bo
    Gonzalez, Frank J.
    Ma, Xiao-Chi
    Sun, Hong-Zhi
    JOURNAL OF LIPID RESEARCH, 2013, 54 (12) : 3334 - 3344
  • [32] Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era?
    Angelin, B
    Eriksson, M
    Rudling, M
    CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) : 269 - 274
  • [33] METABOLISM OF BILE-ACIDS .14. SARCOSINE CONJUGATED BILE-ACIDS
    HATONO, S
    HIRONAKA, Y
    KURAMOTO, T
    HOSHITA, T
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1984, 104 (05): : 466 - 471
  • [35] INFLUENCE OF DIETARY BILE-ACIDS ON FORMATION OF BILE-ACIDS IN RAT
    DANIELSSON, H
    STEROIDS, 1973, 22 (05) : 667 - 676
  • [36] Influence of Bile Acids on Clindamycin Hydrochloride Skin Permeability: In Vitro and In Silico Preliminary Study
    Dragana Zaklan
    Dušan Nešić
    Darko Mitrović
    Slavica Lazarević
    Maja Đanić
    Momir Mikov
    Nebojša Pavlović
    European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 219 - 228
  • [37] INFLUENCE OF PECTIN STRUCTURE ON THE INTERACTION WITH BILE-ACIDS UNDER IN-VITRO CONDITIONS
    DONGOWSKI, G
    ZEITSCHRIFT FUR LEBENSMITTEL-UNTERSUCHUNG UND-FORSCHUNG, 1995, 201 (04): : 390 - 398
  • [38] Influence of Bile Acids on Clindamycin Hydrochloride Skin Permeability: In Vitro and In Silico Preliminary Study
    Zaklan, Dragana
    Nesic, Dusan
    Mitrovic, Darko
    Lazarevic, Slavica
    Danic, Maja
    Mikov, Momir
    Pavlovic, Nebojsa
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (02) : 219 - 228
  • [39] METABOLISM OF ISO-BILE ACIDS IN THE RAT
    SHEFER, S
    SALEN, G
    HAUSER, S
    DAYAL, B
    BATTA, AK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (03) : 1401 - 1406
  • [40] Bile acids and glucocorticoid metabolism in health and disease
    Theiler-Schwetz, Verena
    Zaufel, Alex
    Schlager, Hansjoerg
    Obermayer-Pietsch, Barbara
    Fickert, Peter
    Zollner, Gernot
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (01): : 243 - 251